232 related articles for article (PubMed ID: 11522838)
1. Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.
Lloyd BH; Giles RV; Spiller DG; Grzybowski J; Tidd DM; Sibson DR
Nucleic Acids Res; 2001 Sep; 29(17):3664-73. PubMed ID: 11522838
[TBL] [Abstract][Full Text] [Related]
2. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
3. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
Bruice TW; Lima WF
Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
[TBL] [Abstract][Full Text] [Related]
4. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.
Ho SP; Britton DH; Stone BA; Behrens DL; Leffet LM; Hobbs FW; Miller JA; Trainor GL
Nucleic Acids Res; 1996 May; 24(10):1901-7. PubMed ID: 8657572
[TBL] [Abstract][Full Text] [Related]
5. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
[TBL] [Abstract][Full Text] [Related]
6. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
[TBL] [Abstract][Full Text] [Related]
7. Effects of RNA secondary structure on cellular antisense activity.
Vickers TA; Wyatt JR; Freier SM
Nucleic Acids Res; 2000 Mar; 28(6):1340-7. PubMed ID: 10684928
[TBL] [Abstract][Full Text] [Related]
8. Identification of a good c-myc antisense oligodeoxynucleotide target site and the inactivity at this site of novel NCH triplet--targeting ribozymes.
Giles RV; Spiller DG; Clark RE; Tidd DM
Nucleosides Nucleotides; 1999 Sep; 18(9):1935-44. PubMed ID: 10549146
[TBL] [Abstract][Full Text] [Related]
9. Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
Biotechnol Bioeng; 1999 Oct; 65(1):1-9. PubMed ID: 10440665
[TBL] [Abstract][Full Text] [Related]
10. Fast and accurate determination of sites along the FUT2 in vitro transcript that are accessible to antisense oligonucleotides by application of secondary structure predictions and RNase H in combination with MALDI-TOF mass spectrometry.
Gabler A; Krebs S; Seichter D; Förster M
Nucleic Acids Res; 2003 Aug; 31(15):e79. PubMed ID: 12888531
[TBL] [Abstract][Full Text] [Related]
11. Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro.
Veal GJ; Agrawal S; Byrn RA
Nucleic Acids Res; 1998 Dec; 26(24):5670-5. PubMed ID: 9837998
[TBL] [Abstract][Full Text] [Related]
12. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
Lima WF; Crooke ST
Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
[TBL] [Abstract][Full Text] [Related]
13. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells.
Duroux I; Godard G; Boidot-Forget M; Schwab G; Hélène C; Saison-Behmoaras T
Nucleic Acids Res; 1995 Sep; 23(17):3411-8. PubMed ID: 7567450
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells.
Moulding DA; Giles RV; Spiller DG; White MR; Tidd DM; Edwards SW
Blood; 2000 Sep; 96(5):1756-63. PubMed ID: 10961874
[TBL] [Abstract][Full Text] [Related]
15. Rational selection of antisense oligonucleotide sequences.
Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligonucleotides.
Abe T; Takai K; Nakada S; Yokota T; Takaku H
FEBS Lett; 1998 Mar; 425(1):91-6. PubMed ID: 9541013
[TBL] [Abstract][Full Text] [Related]
17. Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells.
Giles RV; Ruddell CJ; Spiller DG; Green JA; Tidd DM
Nucleic Acids Res; 1995 Mar; 23(6):954-61. PubMed ID: 7731809
[TBL] [Abstract][Full Text] [Related]
18. Antisense properties of tricyclo-DNA.
Renneberg D; Bouliong E; Reber U; Schümperli D; Leumann CJ
Nucleic Acids Res; 2002 Jul; 30(13):2751-7. PubMed ID: 12087157
[TBL] [Abstract][Full Text] [Related]
19. Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase.
Allawi HT; Dong F; Ip HS; Neri BP; Lyamichev VI
RNA; 2001 Feb; 7(2):314-27. PubMed ID: 11233988
[TBL] [Abstract][Full Text] [Related]
20. Fine-tuning of ENA gapmers as antisense oligonucleotides for sequence-specific inhibition.
Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
Oligonucleotides; 2007; 17(3):291-301. PubMed ID: 17854269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
